Trials / Conditions / Unspecified Adult Solid Tumor

Unspecified Adult Solid Tumor

9 registered clinical trials studyying Unspecified Adult Solid Tumor.

Status	Trial	Sponsor	Phase
Withdrawn	Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy NCT03789773	University of Southern California	N/A
Completed	Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors NCT02324621	Rutgers, The State University of New Jersey	Phase 1
Completed	PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced NCT02049593	Jonsson Comprehensive Cancer Center	Phase 1
Active Not Recruiting	Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases NCT01843413	Case Comprehensive Cancer Center	Phase 1
Completed	Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors NCT01450384	Virginia Commonwealth University	Phase 1
Terminated	Stereotactic Radiation Therapy in Treating Patients With Liver Metastases NCT00938457	Mayo Clinic	Phase 1 / Phase 2
Completed	Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin NCT00477607	US Department of Veterans Affairs	Phase 2 / Phase 3
Completed	Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors NCT00390156	University of California, San Francisco	Phase 1
Completed	Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction NCT00037804	Pfizer	Phase 1